Elekta completed the acquisition of Xoft from iCAD.

Elekta, a company that produces and sells advanced medical products for treatment of neurological disorders and radiation of cancer, completed the acquisition of Xoft, a developer od electronic brachytherapy systems for radiation oncology applications from iCAD, a global medical technology producer. Financial terms were not disclosed. “Bringing Xoft’s technology into our portfolio offers exciting prospects to grow the adoption of brachytherapy and provide greater access to patients eligible for this treatment. We will be able to provide a wider range of radiation therapy options that are tailored to the specific needs and preferences of the clinics we support, while helping to reduce their operational costs – since no extensive shielding is needed – and minimize their logistical challenges such as importing radioactive material,” John Lapré, Elekta President Brachy and Neuro Solutions.